4-(3,4-DIMETHOXYPHENYL)-1-ISOPROPYLPIPERIDIN-4-OL
|
- $437 - $3529
- Product name: 4-(3,4-DIMETHOXYPHENYL)-1-ISOPROPYLPIPERIDIN-4-OL
- CAS: 1198286-26-8
- MF: C16H25NO3
- MW: 279.37
- EINECS:
- MDL Number:MFCD07774801
- Synonyms:4-(3,4-DIMETHOXYPHENYL)-1-ISOPROPYLPIPERIDIN-4-OL;4-(3,4-Dimethoxyphenyl)-1-(1-methylethyl)-4-piperidinol;4-Piperidinol, 4-(3,4-dimethoxyphenyl)-1-(1-methylethyl)-
4 prices
Selected condition：
Brand
- Crysdot
Package
- 1g
- 5g
- 10g
- 25g
- ManufacturerCrysdot
- Product numberCD11333848
- Product description4-(3,4-Dimethoxyphenyl)-1-isopropylpiperidin-4-ol 97%
- Packaging1g
- Price$437
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11333848
- Product description4-(3,4-Dimethoxyphenyl)-1-isopropylpiperidin-4-ol 97%
- Packaging5g
- Price$1177
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11333848
- Product description4-(3,4-Dimethoxyphenyl)-1-isopropylpiperidin-4-ol 97%
- Packaging10g
- Price$1965
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11333848
- Product description4-(3,4-Dimethoxyphenyl)-1-isopropylpiperidin-4-ol 97%
- Packaging25g
- Price$3529
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Crysdot | CD11333848 | 4-(3,4-Dimethoxyphenyl)-1-isopropylpiperidin-4-ol 97% | 1g | $437 | 2021-12-16 | Buy |
| Crysdot | CD11333848 | 4-(3,4-Dimethoxyphenyl)-1-isopropylpiperidin-4-ol 97% | 5g | $1177 | 2021-12-16 | Buy |
| Crysdot | CD11333848 | 4-(3,4-Dimethoxyphenyl)-1-isopropylpiperidin-4-ol 97% | 10g | $1965 | 2021-12-16 | Buy |
| Crysdot | CD11333848 | 4-(3,4-Dimethoxyphenyl)-1-isopropylpiperidin-4-ol 97% | 25g | $3529 | 2021-12-16 | Buy |
Properties
Boiling point :412.9±45.0 °C(Predicted)
Density :1.086±0.06 g/cm3(Predicted)
pka :13.89±0.20(Predicted)
Density :1.086±0.06 g/cm3(Predicted)
pka :13.89±0.20(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|